Haleon (HLN) Change in Account Payables (2022 - 2025)

Haleon's (HLN) quarterly Change in Account Payables came in at $143.4 million in Q4 2025, up 12.14% on a QoQ basis from $127.8 million in Q4 2023.

Haleon (HLN) Change in Account Payables (2022 - 2025) Analysis & Trends

Haleon (HLN) has 3 years of Change in Account Payables data on file, last reported at $143.4 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Account Payables (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.33 Bn	2.15 Bn	-
3	Zoetis	31.54 Bn	29.86 Bn	1.05 Bn	-53.00 Mn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	-143.74 Mn
5	United Therapeutics	22.15 Bn	19.48 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-21.20 Mn
7	Neurocrine Biosciences	15.56 Bn	15.17 Bn	935.80 Mn	-
8	Elanco Animal Health	11.74 Bn	11.21 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	-
10	Alkermes	8.11 Bn	7.46 Bn	397.90 Mn	-

Download Data